The Most Common Cause of Chronic Hair Loss in Women
By Grattan Woodson, M.D. FACP
Androgen Alopecia affects half of white women beginning in the mid-thirties, accelerating in the forties and really taking off after menopause. This is a treatable genetic dominantly inherited disorder for which there is no cure but thankfully there is now a very effective therapy. The burden of coping with hair loss is inestimable and is something that never stops only worsening. The hours and fortunes spent camouflaging the problem pay off but are not the solution. There remain so many situations, places and things that remain strictly off limits that you would like to do but can’t because of your hair.
Androgenic alopecia in a middle aged women. Photo from the top of the head with the front of the head at the bottom of the frame. This image shows grade 3-hair loss that is most severe on the crown with sparing of the frontal hairline and vertex. There is generalized hair loss. This patient is an excellent candidate for series of treatments with platelet rich plasma to reawaken her dormant hair follicles that will result in regrowth of new hair beginning in 3 months.
Our scientific understanding of the cause and nature of hair loss in women due to androgenic alopecia has evolved. This has opened up a whole new line of therapy for this condition we call Regenomics. This treatment approach combines platelet-rich plasma, hormone manipulation, stem cell therapy, growth factors, genetics, pharmacology, and cell biology to treat this previously poorly treated common chronic disease.
We confine our treatment to women with androgenic alopecia because it is women who suffer the most due to it. What we offer is a treatment not a cure. Our treatments harness the body’s natural regenerative mechanisms to awaken the dormant hair follicles. This takes time to work and that requires persistence and patience. Women have these virtues especially when it means the difference between having healthy go anywhere do anything natural hair or not.
A profound understanding has evolved in the scientific cause and nature of hair loss due to androgenic alopecia. This has opened up a whole new line of therapy for this previously untouchable condition we call Regenomics. This treatment approach combines platelet-rich plasma, hormone manipulation, stem cell therapy, growth factors, genetics, pharmacology, and cell biology to treat this common chronic disease.
Women suffering from androgenic alopecia have relatively too much dihydrotestosterone DHT, the most potent androgen. It is generated from testosterone by an enzyme called 5R. The reason for the excess DHT is women with AA have too much 5R in their scalp, or too little aromatase the enzyme that converts testosterone to estrogen, or both. These conditions are genetically determined and have been very strongly conserved by natural selection in all human groups.
For a chronic disorder like androgenic alopecia for which there is no cure an effective therapy must be continued for the benefits of therapy to continue. If the therapy is stopped then the benefits will be lost. Another reason we prefer treating women is the dedication they bring to the task of restoring and conserving their newly regrown hair. They do not take their hair for granted. They will not let their guard down harming their hair, not now that its back. We rejoice with them in their success and are committed to stand by them and provide them with all the support we can as they proceed through life with this foe at bay finally under control.